Physician profile
Jonathon Mitchell Brown
NPI 1619242195
$89,250.26
in general payments reported to CMS, 2019-2025
20 companies · $1,360 in 2025
The $1,360 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,870 · 2020: $790 · 2021: $1,958 · 2022: $35K · 2023: $16K · 2024: $27K · 2025: $1,360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $37K · Travel and Lodging: $3,956 · Food and Beverage: $3,834.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $36,941.74 |
| Travel and Lodging | $3,956.01 |
| Food and Beverage | $3,834.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $57,411.10 | 2019-2025 | Mako, Triathlon, Insignia |
| Medical Device Business Services, INC. | $18,043.98 | 2019-2024 | Actis, Reclaim |
| Depuy Synthes Products, INC. | $6,813.18 | 2022-2024 | |
| Depuy Synthes Sales INC. | $5,282.29 | 2019-2020 | |
| Sanara Medtech INC. | $1,035.06 | 2020-2025 | Celleraterx, Biasurge, Celleraterx |
| Zimmer Biomet Holdings, INC. | $233.02 | 2021-2022 | |
| Allergan, INC. | $83.93 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.31 | 2021-2022 | |
| Novus Surgical Consultants | $62.94 | 2024 | |
| Electronic Waveform Lab, INC. | $34.47 | 2025 | |
| Horizon Therapeutics Plc | $25.58 | 2021 | |
| Becton, Dickinson and Company | $24.01 | 2025 | Arista |
| Averitas Pharma INC. | $20.14 | 2025 | Qutenza |
| Pacira Therapeutics, INC. | $20.01 | 2021 | |
| Solventum Corporation | $19.64 | 2025 | Activ.A.C. |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $17.66 | 2022 | |
| Ermi LLC | $16.58 | 2021 | |
| Ferring Pharmaceuticals INC. | $15.92 | 2023 | Euflexxa |
| Collegium Pharmaceutical, INC. | $12.99 | 2022 | |
| Biocomposites INC | $8.45 | 2025 | Stimulan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathon Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.